ArticleOncoTargets and therapy2016

E2A-PBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol.

Yixin Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.